Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Gastric cancer is now listed as a condition term, and a Genetic and Rare Diseases Information Center resource has been added under Resources.
    Difference
    0.2%
    Check dated 2026-02-18T04:40:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2026-02-11T09:28:36.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added a government funding lapse notice regarding NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:02.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary). Updated metadata labels, including a new revision tag (v3.4.0) and lines such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T04:23:35.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 (minor metadata update; content unaffected). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:42:32.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added a Locations section showing California as a study site. The old California Locations label and the HHS Vulnerability Disclosure link were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:28:39.000Z thumbnail image

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.